Cerebral glucose metabolism measured by positron emission tomography in term newborn infants with hypoxic ischemic encephalopathy. 2001

K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
Department of Pediatrics, Lund University Hospital, S-221 85 Lund, Sweden. kristina.thorngren-jerneck@pedi.lu.se

Total and regional cerebral glucose metabolism (CMRgl) was measured by positron emission tomography with 2-((18)F) fluoro-2-deoxy-D-glucose ((18)FDG) in 20 term infants with hypoxic ischemic encephalopathy (HIE) after perinatal asphyxia. All infants had signs of perinatal distress, and 15 were severely acidotic at birth. Six infants developed mild HIE, twelve moderate HIE, and two severe HIE during their first days of life. The positron emission tomographic scans were performed at 4-24 d of age (median, 11 d). One hour before scanning, 2-3.7 MBq/kg (54-100 microCi/kg) (18)FDG was injected i.v. No sedation was used. Quantification of CMRgl was based on a new method employing the glucose metabolism of the erythrocytes, requiring only one blood sample. In all infants, the most metabolically active brain areas were the deep subcortical parts, thalamus, basal ganglia, and sensorimotor cortex. Frontal, temporal, and parietal cortex were less metabolically active in all infants. Total CMRgl was inversely correlated with the severity of HIE (p < 0.01). Six infants with mild HIE had a mean (range) CMRgl of 55.5 (37.7-100.8) micromol.min(-1).100 g(-1), 11 with moderate HIE had 26.6 (13.0-65.1) micromol.min(-1).100 g(-1), and two with severe HIE had 10.4 and 15.0 micromol.min(-1).100 g(-1), respectively. Five of six infants who developed cerebral palsy had a mean (range) CMRgl of 18.1 (10.2-31.4) micromol.min(-1).100 g(-1) compared with 41.5 (13.0-100.8) micromol.min(-1).100 g(-1) in the infants with no neurologic sequela at 2 y. We conclude that CMRgl measured during the subacute period after perinatal asphyxia in term infants is highly correlated with the severity of HIE and short-term outcome.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014055 Tomography, Emission-Computed Tomography using radioactive emissions from injected RADIONUCLIDES and computer ALGORITHMS to reconstruct an image. CAT Scan, Radionuclide,CT Scan, Radionuclide,Computerized Emission Tomography,Radionuclide Tomography, Computed,Scintigraphy, Computed Tomographic,Tomography, Radionuclide-Computed,Computed Tomographic Scintigraphy,Emission-Computed Tomography,Radionuclide Computer-Assisted Tomography,Radionuclide Computerized Tomography,Radionuclide-Computed Tomography,Radionuclide-Emission Computed Tomography,Tomography, Computerized Emission,CAT Scans, Radionuclide,CT Scans, Radionuclide,Computed Radionuclide Tomography,Computed Tomography, Radionuclide-Emission,Computer-Assisted Tomographies, Radionuclide,Computer-Assisted Tomography, Radionuclide,Computerized Tomography, Radionuclide,Emission Computed Tomography,Emission Tomography, Computerized,Radionuclide CAT Scan,Radionuclide CAT Scans,Radionuclide CT Scan,Radionuclide CT Scans,Radionuclide Computed Tomography,Radionuclide Computer Assisted Tomography,Radionuclide Computer-Assisted Tomographies,Radionuclide Emission Computed Tomography,Scan, Radionuclide CAT,Scan, Radionuclide CT,Scans, Radionuclide CAT,Scans, Radionuclide CT,Tomographic Scintigraphy, Computed,Tomographies, Radionuclide Computer-Assisted,Tomography, Computed Radionuclide,Tomography, Emission Computed,Tomography, Radionuclide Computed,Tomography, Radionuclide Computer-Assisted,Tomography, Radionuclide Computerized,Tomography, Radionuclide-Emission Computed
D019788 Fluorodeoxyglucose F18 The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162) 18F Fluorodeoxyglucose,18FDG,2-Fluoro-2-deoxy-D-glucose,2-Fluoro-2-deoxyglucose,Fludeoxyglucose F 18,18F-FDG,Fluorine-18-fluorodeoxyglucose,Fluorodeoxyglucose F 18,2 Fluoro 2 deoxy D glucose,2 Fluoro 2 deoxyglucose,F 18, Fludeoxyglucose,F 18, Fluorodeoxyglucose,F18, Fluorodeoxyglucose,Fluorine 18 fluorodeoxyglucose,Fluorodeoxyglucose, 18F
D020925 Hypoxia-Ischemia, Brain A disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions. Anoxia-Ischemia, Brain,Anoxia-Ischemia, Cerebral,Anoxic-Ischemic Encephalopathy,Brain Anoxia-Ischemia,Brain Hypoxia-Ischemia,Brain Ischemia-Anoxia,Brain Ischemia-Hypoxia,Cerebral Anoxia-Ischemia,Cerebral Hypoxia-Ischemia,Cerebral Ischemia-Anoxia,Cerebral Ischemia-Hypoxia,Hypoxia-Ischemia, Cerebral,Hypoxic-Ischemic Encephalopathy,Ischemia-Anoxia, Brain,Ischemia-Anoxia, Cerebral,Ischemia-Hypoxia, Brain,Ischemia-Hypoxia, Cerebral,Ischemic-Hypoxic Encephalopathy,Encephalopathy, Anoxic-Ischemic,Encephalopathy, Hypoxic-Ischemic,Anoxia Ischemia, Brain,Anoxia Ischemia, Cerebral,Anoxia-Ischemias, Brain,Anoxia-Ischemias, Cerebral,Anoxic Ischemic Encephalopathy,Anoxic-Ischemic Encephalopathies,Brain Anoxia Ischemia,Brain Anoxia-Ischemias,Brain Hypoxia Ischemia,Brain Hypoxia-Ischemias,Brain Ischemia Anoxia,Brain Ischemia Hypoxia,Brain Ischemia-Anoxias,Brain Ischemia-Hypoxias,Cerebral Anoxia Ischemia,Cerebral Anoxia-Ischemias,Cerebral Hypoxia Ischemia,Cerebral Hypoxia-Ischemias,Cerebral Ischemia Anoxia,Cerebral Ischemia Hypoxia,Cerebral Ischemia-Anoxias,Cerebral Ischemia-Hypoxias,Encephalopathies, Anoxic-Ischemic,Encephalopathies, Hypoxic-Ischemic,Encephalopathies, Ischemic-Hypoxic,Encephalopathy, Anoxic Ischemic,Encephalopathy, Hypoxic Ischemic,Encephalopathy, Ischemic-Hypoxic,Hypoxia Ischemia, Brain,Hypoxia Ischemia, Cerebral,Hypoxia-Ischemias, Brain,Hypoxia-Ischemias, Cerebral,Hypoxic Ischemic Encephalopathy,Hypoxic-Ischemic Encephalopathies,Ischemia Anoxia, Brain,Ischemia Anoxia, Cerebral,Ischemia Hypoxia, Brain,Ischemia Hypoxia, Cerebral,Ischemia-Anoxias, Brain,Ischemia-Anoxias, Cerebral,Ischemia-Hypoxias, Brain,Ischemia-Hypoxias, Cerebral,Ischemic Hypoxic Encephalopathy,Ischemic-Hypoxic Encephalopathies

Related Publications

K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
April 1983, Developmental medicine and child neurology,
K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
December 2003, Pediatric research,
K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
January 1987, Biological psychiatry,
K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
February 2012, Pediatric neurology,
K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
January 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
February 1987, The New England journal of medicine,
K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
May 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
August 2014, Medical science monitor : international medical journal of experimental and clinical research,
K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
August 1993, Journal of the neurological sciences,
K Thorngren-Jerneck, and T Ohlsson, and A Sandell, and K Erlandsson, and S E Strand, and E Ryding, and N W Svenningsen
August 2002, Synapse (New York, N.Y.),
Copied contents to your clipboard!